Search

Minh Gia Ma

from Huntington Beach, CA
Age ~79
Get Report
Also known as:
Minh G Ma, Minh Gia, Gia Ma Minh, Ma Minh Gia
Phone and address:
20411 Allport Ln, Huntington Beach, CA 92646
(714) 964-7591
Related to:
Hoa N Pham, 52Joseph Magia, 42Anh Pham, 68Paul Magia, 39Maithao Pham, 70Cathy Magia, 47
Connected to:
Ah N Ma, 70Aileen B Ma, 51Akana K Ma, 68Alex B Ma, 49Alexandra Ma, 33Allan Ma, 39Anni Ma, 39Annie Ma, 49Athena Ma, 30Ayan S Ma, 38

Minh Ma Phones & Addresses

  • 20411 Allport Ln, Huntingtn Bch, CA 92646 (714) 964-7591
  • Huntington Beach, CA
  • Fountain Valley, CA
  • Tustin, CA
  • Middlesex, NJ
  • Bronx, NY
  • Bound Brook, NJ

Resumes

Resumes

Minh Ma Photo 1

Minh Ma

View page
Minh Ma Photo 2

Minh Ma

View page
Minh Ma Photo 3

Technology Specialist

View page
Work:

Technology Specialist
Minh Ma Photo 4

It Technician At Hp

View page
Location:
Greater Los Angeles Area
Industry:
Computer Hardware

Business Records

Name / Title
Company / Classification
Phones & Addresses
Minh Ma
Partner
Hoang Oanh Music Center
Whol Durable Goods
20411 Allport Ln, Huntington Beach, CA 92646
(714) 964-7591
Minh Quoc Ma
President
P & L FASHION INC
151 W Wl St, San Gabriel, CA 91776
Minh Mien Ma
President
A XUONG THREAD CORPORATION
Mfg Thread
9452 E Garvey Ave STE B, South El Monte, CA 91733
(626) 350-3281

Publications

Us Patents

Medical Implant With Reinforcement Mechanism

View page
US Patent:
20070038297, Feb 15, 2007
Filed:
Aug 11, 2006
Appl. No.:
11/502879
Inventors:
Donald Bobo - Santa Ana CA, US
George Bakis - La Habra Heights CA, US
Minh Ma - Santa Ana CA, US
International Classification:
A61F 2/24
US Classification:
623002360, 606151000
Abstract:
An improved medical implant for treating mitral regurgitation is provided. The medical implant comprises proximal and distal anchors connected by a bridge. The medical implant is configured to be delivered into a coronary sinus using a minimally invasive procedure. The bridge is preferably made of a shape memory material which is biased to contract after the implant is delivered. The medical implant further comprises a reinforcement mechanism configured to limit stresses and strains along the length of the bridge. In a preferred embodiment, the reinforcement mechanism is fixed to a plurality of attachment points along the bridge, thereby preventing excessive elongation between any two attachment points. A resorbable material is preferably disposed within gaps along the length of the bridge to temporarily maintain the bridge in an elongated condition. After the proximal and distal anchors are secured in the coronary sinus, the resorbable material gradually resorbs, thereby creating tension in the bridge which applies a force along the mitral valve annulus. The reinforcement mechanism ensures that stresses and strains and distributed evenly while the bridge is in tension.

Medical Implant With Reinforcement Mechanism

View page
US Patent:
20080221673, Sep 11, 2008
Filed:
Feb 15, 2008
Appl. No.:
12/032616
Inventors:
Donald Bobo - Santa Ana CA, US
George Bakis - La Habra Heights CA, US
Minh T. Ma - Santa Ana CA, US
Philip P. Corso - Irvine CA, US
International Classification:
A61F 2/24
US Classification:
623 236
Abstract:
An improved medical implant for treating mitral regurgitation is provided. The medical implant comprises proximal and distal anchors connected by a bridge. The medical implant is configured to be delivered into a coronary sinus using a minimially invasive procedure. The bridge is preferably made of a shape memory material which is biased to contract after the implant is delivered. The medical implant further comprises a reinforcement mechanism configured to limit stresses and strains along the length of the bridge. In a preferred embodiment, the reinforcement mechanism is fixed to a plurality of attachment points along the bridge, thereby preventing excessive elongation between any two attachment points. A resorbable material is preferably disposed within gaps along the length of the bridge to temporarily maintain the bridge in an elongated condition. After the proximal and distal anchors are secured in the coronary sinus, the resorbable material gradually resorbs, thereby creating tension in the bridge which applies a force along the mitral valve annulus. The reinforcement mechanism ensures that stresses and strains and distributed evenly while the bridge is in tension.

Retaining Mechanisms For Prosthetic Valves

View page
US Patent:
20120022633, Jan 26, 2012
Filed:
Jul 22, 2011
Appl. No.:
13/188988
Inventors:
Christopher Olson - Aliso Viejo CA, US
Glen T. Rabito - Newport Beach CA, US
Dustin P. Armer - Aliso Viejo CA, US
Minh Ma - Santa Ana CA, US
Devin Marr - Newport Beach CA, US
Mark Huang - Laguna Nigel CA, US
Hiroshi Okabe - Irvine CA, US
Kevin Stewart - Newport Beach CA, US
Alison S. Curtis - Irvine CA, US
International Classification:
A61F 2/84
A61F 2/24
US Classification:
623 111, 623 211
Abstract:
Disclosed herein are representative embodiments of methods, apparatus, and systems used to deliver a prosthetic heart valve to a deficient valve. In one embodiment, for instance, a support structure and an expandable prosthetic valve are advanced through the aortic arch of a patient using a delivery system. The support structure is delivered to a position on or adjacent to the surface of the outflow side of the aortic valve (the support structure defining a support-structure interior). The expandable prosthetic valve is delivered into the aortic valve and into the support-structure interior. The expandable prosthetic heart valve is expanded while the expandable prosthetic heart valve is in the support-structure interior and while the support structure is at the position on or adjacent to the surface of the outflow side of the aortic valve, thereby causing one or more native leaflets of the aortic valve to be frictionally secured between the support structure and the expanded prosthetic heart valve.

Microvessel Cell Isolation Apparatus

View page
US Patent:
54098335, Apr 25, 1995
Filed:
Jul 1, 1993
Appl. No.:
8/086778
Inventors:
Can B. Hu - Irvine CA
Minh T. Ma - Santa Ana CA
Than Nguyen - Huntington Beach CA
Richard Rhee - Diamond Bar CA
Keith Myers - El Toro CA
Assignee:
Baxter International Inc. - Deerfield IL
International Classification:
C12M 142
US Classification:
435288
Abstract:
A processing vessel for isolating microvessel endothelial cells from liposuctioned fat tissues includes a fat-receiving basket defined by polyester screen material. Fat tissue removed from a patient by liposuction is received into the basket and is rinsed and digested with an enzymatic solution. The freed microvessel endothelial cells from the fat tissues are separated from the fat cells, and from blood cells and other materials which may be present in the basket by centrifuging. A bottom chamber of the processing vessel is configured to define a "pellet" of isolated endothelial cells which may be removed from the processing vessel for deposition on the inner lumenal surface of a synthetic graft which the fat-donor patient is to receive.

Method For Inhibiting Chymopapain And Papain Enzyme Activity With Polysaccharides Of Animal Origin

View page
US Patent:
56703589, Sep 23, 1997
Filed:
Oct 19, 1995
Appl. No.:
8/545439
Inventors:
Catherine T. Lee - Laguna Hills CA
Cynthia Zerfass - Trabuco Canyon CA
Tan Thanh Dinh - Garden Grove CA
Minh T. Ma - Santa Ana CA
Assignee:
Baxter International Inc. - Deerfield IL
International Classification:
C12N 948
C07G 1700
C07G 1500
US Classification:
435212
Abstract:
The activities of chymopapain or papain in enzyme mixtures are inhibited by the addition of glycogen, hyaluronic acid, or desulfated heparin. The process for isolating viable hepatocytes or pancreatic cells by treatment with papain or chymopapain is improved by terminating the treatment by inhibiting the reaction with these polysaccharides. Similarly, the process for removing undesired tissue by treatment with papain or chymopapain is improved by terminating the treatment by inhibiting the reaction with these polysaccharides.

Method And Apparatus For Sodding Microvessel Cells Onto A Synthetic Vascular Graft

View page
US Patent:
58043667, Sep 8, 1998
Filed:
Feb 9, 1995
Appl. No.:
8/386048
Inventors:
Can B. Hu - Irvine CA
Minh T. Ma - Santa Ana CA
Than Nguyen - Huntington Beach CA
Richard Rhee - Diamond Bar CA
Keith Myers - Lake Forest CA
Assignee:
Baxter International Inc. - Deerfield IL
International Classification:
C12M 308
C12N 508
US Classification:
435 11
Abstract:
An apparatus for sodding onto the inner lumenal surface of a synthetic graft of harvested and concentrated microvessel endothelial cells from liposuctioned fat tissues, which harvested cells are formed into a "pellet" of isolated endothelial cells in loose aggregations, includes a sodding tube having a single rigid outer wall bounding a sodding chamber. A filter pack assembly is provided to communicate the pellet of cells from a processing vessel to the graft. This filter pack assembly includes a series of successively finer filter members cooperatively defining a series of turbulent-flow chambers in which aggregations of cells too large to pass through a particular filter are exposed to liquid flow turbulence which is effective to break up the aggregations. A check valve assembly ensures that liquid flow is unidirectional so that sodding of the cells onto the inner lumenal surface of the graft is not interfered with by possible liquid reflux, and sodded cells are similarly not dislodged from the graft by such liquid reflux.

S309 Chimeric Antigen Receptors And Methods Of Use

View page
US Patent:
20220184125, Jun 16, 2022
Filed:
Dec 14, 2021
Appl. No.:
17/551006
Inventors:
- New Brunswick NJ, US
Minh Ma - New Brunswick NJ, US
Saiaditya Badeti - New Brunswick NJ, US
Assignee:
Rutgers, The State University of New Jersey - New Brunswick NJ
International Classification:
A61K 35/17
C07K 14/725
A61P 31/14
C07K 14/715
C07K 14/54
C07K 16/10
C07K 14/705
A61K 38/00
A61K 39/00
Abstract:
Chimeric antigen receptors (CARs) including an scFv binding to coronavirus spike protein (S309 scFv), nucleic acids encoding the CARs, vectors including nucleic acids encoding the CARs, and cells expressing the CARs are provided. Methods of treating a subject with coronavirus are also provided, including administering to the subject a modified immune cell expressing a disclosed CAR.

Retaining Mechanisms For Prosthetic Valves

View page
US Patent:
20200113686, Apr 16, 2020
Filed:
Dec 9, 2019
Appl. No.:
16/708267
Inventors:
- Irvine CA, US
Glen T. Rabito - Lake Forest CA, US
Dustin P. Armer - Costa Mesa CA, US
Minh T. Ma - Santa Ana CA, US
Devin H. Marr - Westford MA, US
Cheng-Tung Huang - Laguna Niguel CA, US
Hiroshi Okabe - Costa Mesa CA, US
Kevin M. Stewart - Corona CA, US
Alison S. Curtis - Costa Mesa CA, US
International Classification:
A61F 2/24
Abstract:
Disclosed herein are representative embodiments of methods, apparatus, and systems used to deliver a prosthetic heart valve to a deficient valve. In one embodiment, for instance, a support structure and an expandable prosthetic valve are advanced through the aortic arch of a patient using a delivery system. The support structure is delivered to a position on or adjacent to the surface of the outflow side of the aortic valve (the support structure defining a support-structure interior). The expandable prosthetic valve is delivered into the aortic valve and into the support-structure interior. The expandable prosthetic heart valve is expanded while the expandable prosthetic heart valve is in the support-structure interior and while the support structure is at the position on or adjacent to the surface of the outflow side of the aortic valve, thereby causing one or more native leaflets of the aortic valve to be frictionally secured between the support structure and the expanded prosthetic heart valve.
Control profile
Minh Gia Ma from Huntington Beach, CA, age ~79 Get Report